| Literature DB >> 32526182 |
Michail S Lionakis1, Tobias M Hohl2.
Abstract
Nosocomial fungal infections require a robust scientific response to complement antifungal development and the implementation of infection control measures. This Commentary discusses how a parallel effort to address fungal pathogenesis and antifungal immunity, the mycobiota and colonization resistance, and risk factors is essential to reduce the toll of these infections.Entities:
Mesh:
Substances:
Year: 2020 PMID: 32526182 PMCID: PMC7543769 DOI: 10.1016/j.chom.2020.04.011
Source DB: PubMed Journal: Cell Host Microbe ISSN: 1931-3128 Impact factor: 21.023